Not a good buy right now: price is in a clear bearish trend with negative momentum and no proprietary buy signals.
Oversold (RSI_6 ~10.6) can create short bounces, but the broader trend and deteriorating fundamentals make the risk/reward unattractive for an impatient buyer.
With no recent news catalysts, no options-sentiment read, and sharply weaker 2025/Q3 financials, the setup favors avoiding/stepping aside rather than buying.
Momentum: MACD histogram at -0.0109 and negatively expanding = downside momentum is strengthening.
RSI: RSI_6 at 10.624 = extremely oversold; this can trigger a short-term bounce, but oversold alone is not a buy signal in a strong downtrend.
Key levels: Pivot 0.747 is well above current price (0.535), showing the stock is trading below an important reference level.
Support/Resistance: Nearby support S2 ~0.501 (risk of another leg down if it breaks); resistance levels at S1 ~0.595 then Pivot ~0.747.
Pattern-based outlook: Similar-pattern stats suggest ~50% chance of -2.03% next day, -1.34% next week, and +1.87% next month—near-term bias still slightly negative.
Positive Catalysts
Extremely oversold RSI may fuel a technical dead-cat bounce.
Pre-market showing +3.33% suggests occasional dip-buying interest at these depressed levels.
Hedge funds and insiders: Neutral (no notable recent trend), reducing risk of an immediate negative “smart money” signal.
Neutral/Negative Catalysts
keeps the technical bias negative.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 493,104, down -85.58% YoY (sharp contraction).
Net income: -3,729,128, down -663.51% YoY (loss widened materially).
EPS: -1.29, down -229.00% YoY (profitability trend deteriorating).
Gross margin: 100 (reported as increased; however, revenue collapse and larger losses dominate the overall fundamental picture).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price-target change data provided in the dataset; no clear Wall Street pros/cons trend can be verified from the inputs.
Based on the available data alone (weak fundamentals + bearish technicals + no catalysts), the balance of evidence skews negative rather than supportive of a buy.
Politicians/Congress/influential trading: No recent congress trading data available (no confirmed signal from that channel).
Wall Street analysts forecast ENSC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENSC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast ENSC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENSC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
